Effect of leptin on vascular calcification in apolipoprotein E-deficient mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 29, Issue 12, 2009, Pages 2069-2075

  Zeadin, Melec ^a   Butcher, Martin ^a   Werstuck, Geoff ^a   Khan, Mohammad ^a   Yee, Colin K ^a   Shaughnessy, Stephen G ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Atherosclerosis; Leptin; Osteoblasts; Valvular stenosis; Vascular calcification

Indexed keywords

ALKALINE PHOSPHATASE; APOLIPOPROTEIN E; CHOLESTEROL; GLUCOSE; INSULIN; LEPTIN; OSTEOCALCIN; OSTEOPONTIN; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA ROOT; AORTA VALVE; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL CALCIFICATION; CELL DIFFERENTIATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; HEART VALVE; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SURFACE PROPERTY; THORACIC AORTA; TRIACYLGLYCEROL BLOOD LEVEL;

ALKALINE PHOSPHATASE; ANIMALS; AORTA; AORTIC VALVE; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BODY WEIGHT; CALCINOSIS; CATTLE; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LEPTIN; LIPIDS; MICE; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; OSTEOBLASTS; OSTEOCALCIN; OSTEOPONTIN; RECOMBINANT PROTEINS; RISK FACTORS;

EID: 73849099769     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.195255     Document Type: Article

References (44)

1. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol. 2005;288:H2031-H2041.
2. Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C. Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res. 2005;126:121-129.
3. Reilly MP, Iqbal N, Schutta M, Wolfe ML, Scally WM, Localio AR, Rader DJ, Kimmel SE. Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. J Clin Endocrinol Metab. 2004;89: 3872-3878.
4. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, Sattar N. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronoary Prevention Study (WOSCOPS). Circulation. 2001;104:3052-3056.
5. Konstantinides S, Schafer K, Koschnick S, Loskutoff DJ. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest. 2001; 108:1533-1540.
6. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM. Leptin regulates proinflammatory responses. FASEB J. 1998;12:57-65.
7. Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzman M, Brownlee M. Leptin induces mitochondrial superoxide production and monocyte che-moattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem. 2001;276: 25096-25100.
8. Oda A, Taniguchi T, Yokoyama M. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci. 2001;47: 141-150.
9. Shafer K, Halle M, Goeschen C, Dellas C, Pynn M, Loskutoff DJ, Konstantinides S. Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol. 2004;24:112-117.
10. Bodary PF, Gu S, Shen Y, Hasty AH, Buckler JM, Eitzman DT. Recombinant leptin promotes atherosclerosis and thrombosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2005;25:e119-e122.
11. Chiba T, Shinozaki S, Nakazawa T, Kawakami A, Ai M, Kaneko E, Kitagawa M, Kondo K, Chait A, Shimokado K. Leptin deficiency suppresses progression of atherosclerosis in apoE-deficient mice. Atherosclerosis. 2007; 196:68-75.
12. Parhami F, Tintut Y, Ballard A, Fogelman AM, Demer LL. Leptin enhances the calcification of vascular cells. Circ Res. 2001;88:954-960.
13. Sugioka K, Hozumi T, Sciacca RR, Miyake Y, Totova I, Gaspard G, Sacco RL, Homma S, Di Tullio MR. Impact of aortic stiffness on ischemic stroke in elderly patients. Stroke. 2002;33:2077-2081.
14. Seely S. On arterial calcification. Int J Cardiol. 1997;61:105-108.
15. Ohtsuka S, Kakihana M, Watanabe H, Sugishita Y. Chronically decreased aortic distensibility causes deterioration of coronary perfusion during increased left ventricular contraction. J Am Coll Cardiol. 1994;24: 1406-1414.
16. Iribarren C, Sidney S, Sternfeld B, Browner WS. Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA. 2000;283:2810-2815.
17. Arad Y, Spadaro LA, Goodman K, Newstein D, Guerci AD. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol. 2000;36:1253-1260.
18. Vliegenthart R, Oudkerk M, Song B, van der Kuip DA, Hofman A, Witteman JC. Coronary calcification detected by electron-beam computed tomography and myocardial infarction. The Rotterdam Coronary Calcification Study. Eur Heart J. 2002;23:1596-1603. (Pubitemid 35221564)
19. Virmani R, Farb A, Burke AP. Coronary angioplasty from the perspective of atherosclerotic plaque: morphological predictors of immediate success and restenosis. Am Heart J. 1994;127:163-179.
20. Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty: an observational study using intravascular ultrasound. Circulation. 1992;86:64-70.
21. Haude M, Erbel R, Straub U. Results of intracoronary stents for management of coronary dissection after balloon angioplasty. Am J Cardiol. 1991;67:691-696.
22. Fischman DL, Leon MB, Baim DS, Schatz RA. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501.
23. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM. Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. J Am Coll Cardiol. 1997;29: 630-634.
24. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220-1225.
25. Phan O, Ivanovski O, Nguyen-Khoa T, Mothu N, Angulo J, Westenfeld R, Ketteler M, Meert N, Maizel J, Nikolov IG, Vanholder R, Lacour B, Drüeke TB, Massy ZA. Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice. Circulation. 2005; 112:2975-12882
26. -/-) mice with chronic renal failure. Nephrol Dial Transplant. 2008;23:82-90.
27. Yang L, Butcher M, Simon R, Osip S, Shaughnessy S. The effect of heparin on osteoblast differentiation and activity in primary cultures of bovine aortic smooth muscle cells. Atherosclerosis. 2005;179:79-86.
28. Bear M, Butcher M, Shaughnessy S. Oxidized low-density lipoprotein acts synergistically with /3-glycerophosphate to induce osteoblast differentiation in primary cultures of vascular smooth muscle cells. J Cell Biochem. 2008;105:185-193.
29. Bidder M, Latifi T, Towler D. Reciprocal temporospatial patterns of Msx2 and Osteocalcin gene expression during murine odontogenesis. J Bone Miner Res. 1998;13:609-619.
30. Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, Tordoir JH, Spronk HM, Vermeer C, Daemen MJ. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arteriol Thromb Vasc Biol. 2001;21:1998-2003.
31. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest. 1993;91:1800-1809.
32. Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest. 1994;93:2393-2402.
33. Tyson KL, Reynolds JL, McNair R, Zhang Q, Weissberg PL, Shanahan CM. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol. 2003;23:489-494.
34. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997;386:78-81.
35. Schinke T, Karsenty G. Vascular calcification-a passive process in need of inhibitors. Nephrol Dial Transplant. 2000;15:1272-1274.
36. Price PA, Thomas GR, Pardini AW, Figueira WF, Caputo JM, Williamson MK. Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix GLA protein in the serum of etidronate-treated rats. J Biol Chem. 2002;277:3926-3934.
37. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997; 89:309-319.
38. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli S, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 1998;12:1260-1268.
39. Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology. 1999; 140:1630-1638.
40. Gordeladze JO, Drevon CA, Syverson U, Reseland JE. Leptin stimulates osteoblastic proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis and osteoclastic signaling. J Cell Biochem. 2002;85:825-836.
41. Glader CA, Birgander LS, Soderberg S, Ildgruben HP, Saikku P, Waldenstrom A, Dahlen GH Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis. European Heart J. 2003;24:198-208.
42. Boudoulas H, Vavuranakis M, Wooley CF. Valvular heart disease: the influence of changing etiology on nosology. J Heart Valve Dis. 1994;3: 516-526.
43. Passik CS, Ackerman DM, Pluth JR, Edwards WD. Temporal changes in the causes of aortic stenosis: a surgical pathologic study of 646 cases. Mayo Clin Proc. 1987;62:119-123.
44. Qasim A, Mehta NN, Tadesse MG, Wolfe ML, Rhodes T, Girman C, Reilly MP. Adipokines, insulin resistance and coronary artery calcification. J Am Coll Cardiol. 2008;52:231-236.